Given the largely documented role of SDF-1α/CXCR4 axis in modulating cancer cell migration [52–54], we next assessed the ability of PPARγ agonist to influence cell migration and invasion of both breast cancer cells. This evidence concerns the gene CXCL12 and cancer.